Barely Significant
← all excerpts

Have lessons from past failures brought us closer to the success of immunotherapy in metastatic pancreatic cancer?

Oncoimmunology · 2016 · PMC4839322 · PMID 27141395

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantp = 0.001actually significant
A highly significant 91% increase in median PFS from 2.3 mo in the gemcitabine group to 4.4 mo in the IMM-101 plus gemcitabine group was observed (HR 0.46; 95% CI 0.28–0.75; p = 0.001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.